抗膜聯(lián)蛋白A5(ANXA5)單克隆抗體
Anti-Annexin V (ANXA5) Monoclonal Antibody
ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha
- 編號FAA259Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價C10
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 且適物種-
- 應(yīng)用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價格 ¥ 720 ¥ 1200 ¥ 1920 ¥ 2400 ¥ 4200
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Human?HepG2?cell?line?was?fixed?with?2-4%?paraformaldehyde?(10?min)?,?permeabilised?with?0.1%?BSA-Triton?X-100,then?stained?with?20μg/ml?mouse?Anti-human?ANXA5?Monoclonal?Antibody?(Catalog?#?FAA259Hu02,?red?histogram)?or?Isotype?control?antibody?(Catalog?#?IS067-Mu01,?green?histogram),?followed?by?1μg/ml?FITC-conjugated?Anti-mouse?IgG?Secondary?Antibody?(Catalog?#?SAA544Mu18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
For flow cytometry, the suggested use of this reagent is 0.5-1 μg per 10^6 cells in 100 μl volume.
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA259Hu02 | 膜聯(lián)蛋白A5(ANXA5)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA259Hu03 | 膜聯(lián)蛋白A5(ANXA5)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA259Hu04 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA259Hu01 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA259Hu06 | 膜聯(lián)蛋白A5(ANXA5)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA259Hu01 | 膜聯(lián)蛋白A5(ANXA5)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA259Hu05 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA259Hu61 | 膜聯(lián)蛋白A5(ANXA5)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA259Hu61 | 膜聯(lián)蛋白A5(ANXA5)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA259Hu06 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA259Hu03 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA259Hu02 | 膜聯(lián)蛋白A5(ANXA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA259Hu01 | 膜聯(lián)蛋白A5(ANXA5)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA259Hu71 | 膜聯(lián)蛋白A5(ANXA5)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA259Hu81 | 膜聯(lián)蛋白A5(ANXA5)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAA259Hu24 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA259Hu21 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA259Hu22 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | WB; IHC |
| MAA259Hu23 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | WB; IHC; ICC; IP. |
| FAA259Hu04 | 抗膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | FCM |
| FAA259Hu02 | 抗膜聯(lián)蛋白A5(ANXA5)單克隆抗體 | FCM |
| LAA259Hu82 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA259Hu72 | 膜聯(lián)蛋白A5(ANXA5)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| FAA259Hu82 | 抗膜聯(lián)蛋白A5(ANXA5)單克隆抗體(異硫氰酸熒光素標記) | FCM |
| SEA259Hu | 膜聯(lián)蛋白A5(ANXA5)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA259Hu | 膜聯(lián)蛋白A5(ANXA5)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Molecular Biology | Markers of apoptotic dysfunctions in schizophrenia [Pubmed: 24466757] |
| Neuroscience and Behavioral Physiology | Involvement of Anomalous Apoptosis in Impairments to Synaptic Plasticity in Post-Traumatic Stress Disorder [Springer: Source] |
| Inflammation and Cell Signaling | Collectins, C3 complement protein, annexin V and C-reactive protein in acute ischemic stroke: interrelation and implication to upregulated apoptosis and inflammation [Smartscitech: Source] |
| Lung | Annexin A5 Protein as a Potential Biomarker for the Diagnosis of Asthma [Pubmed: 30182154] |
留言咨詢
